Sage Journals: Discover world-class research

Abstract

We found, in 1994, that the epitope for anticardiolipin antibodies (aCL) developed when β2-glycoprotein I (β2GPI) was adsorbed on polyoxygenated polystyrene plates. We also found, in 2009, that the cleaved form of β2GPI (nicked β2GPI) was bound to angiostatin 4.5 and attenuated its antiangiogenic property. We described in 2000 that antiprothrombin antibodies were bound to prothrombin exposed to immobilized phosphatidylserine (aPS/PT) and more than 95% of antiphospholipid syndrome patients who were positive for aPS/PT had lupus anticoagulant. We demonstrated that in the cells stimulated by human monoclonal anti-β2GPI antibodies, p38 mitogen-activated protein kinase phosphorylation was observed in the presence of β2GPI. Furthermore, we found that complement activation was essential for thrombus formation in patients with the antiphospholipid syndrome in vivo.

Keywords

Anticardiolipin antibodies antiphospholipid syndrome lupus anticoagulant thrombosis

Get full access to this article

View all access options for this article.

References

Koike

Sueishi

Funaki

. Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984; 56: 193–199.

Matsuura

Igarashi

Yasuda

. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457–462.

Atsumi

Ieko

Bertolaccini

. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000; 43: 1982–1993.

Yasuda

Atsumi

Ieko

. Nicked β2-glycoprotein I: A marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis. Blood 2004; 103: 3766–3772.

Nakagawa

Yasuda

Matsuura

. Nicked β2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property. Blood 2009; 114: 2553–2559.

Bohgaki

Atsumi

Yamashita

. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-β2Glycoprotein I antibodies. Int Immunol 2001; 16: 1633–1641.

Agar

Gwendolyn

van Os

. β2-glycoprotein I can exist in 2 conformations: Implications for our understanding of the antiphospholipid syndrome. Blood 2010; 116: 1336–1343.

Oku

Atsumi

Bohgaki

. Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis 2009; 68: 1030–1035.

Meroni

Borghi

Raschi

. Pathogenesis of antiphospholipid syndrome: Understanding the antibodies. Nat Rev Rheumatol 2011; 7: 330–339.

10.

Yasuda

Atsumi

Matsuura

. Significance of valine/leucine247 polymorphism of β2-glycoprotein I in antiphospholipid syndrome: Increased reactivity of anti-β2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant. Arthritis Rheum 2005; 52: 212–218.

11.

Horita

Atsumi

Yoshida

. STAT4 single nucleotide polymorphism, rs7574865 G/T, as a risk for antiphospholipid syndrome. Ann Rheum Dis 2009; 68: 1366–1367.

My contribution,my dream – a look at the future of APS

Abstract

Keywords

Get full access to this article

References